Amy Sorgent
Family · San Diego, CANPI 1003117763
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,605 and has fallen 94.0% since, to $96 in 2025.
Across 140 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$526
- Pfizer$239
- AstraZeneca$204
- Gilead$198
- Amgen$195
- Boehringer Ingelheim$186
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $526 |
| Pfizer | 12 | $239 |
| AstraZeneca(2 entities) | 11 | $204 |
| Gilead | 7 | $198 |
| Amgen | 10 | $195 |
| Boehringer Ingelheim | 9 | $186 |
| Novo Nordisk | 9 | $147 |
| Antares Pharma, Inc. | 5 | $111 |
| GSK | 4 | $109 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| Merck | 4 | $93 |
| Johnson & Johnson | 5 | $88 |
| Biohaven Pharmaceuticals, Inc. | 4 | $82 |
| Novartis | 3 | $73 |
| Currax Pharmaceuticals LLC | 4 | $69 |
| Amarin Pharma, Inc. | 3 | $66 |
| Astellas Pharma US Inc | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Axonics, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| VBI Vaccine (delaware) Inc. | 1 | $23 |
| Bayer | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
| Seqirus USA Inc | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,874 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 50 | $1,120 |
| Mirtazapine | 20 | $551 |
| Citalopram HbrCitalopram Hydrobromide | 25 | $524 |
| ClopidogrelClopidogrel Bisulfate | 12 | $381 |
| Pantoprazole Sodium | 11 | $317 |
| Tamsulosin Hcl | 11 | $304 |
| Metformin Hcl ErMetformin Hcl | 13 | $265 |
| Lisinopril | 12 | $246 |
| Trazodone Hcl | 18 | $209 |
Paid to pharmacies, not to this prescriber.
Other family in San Diego
- Dawn MeyerSan Diego$270K
- Erin DwyerSan Diego$189K
- Lizaveta NikitsinaSan Diego$36K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Jennifer KangCerritos$255K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.